| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | EGF_3 | 9.57e-03 | 235 | 12 | 2 | PS50026 | |
| Domain | EGF-like_dom | 1.07e-02 | 249 | 12 | 2 | IPR000742 | |
| Domain | EGF_1 | 1.12e-02 | 255 | 12 | 2 | PS00022 | |
| Domain | EGF-like_CS | 1.17e-02 | 261 | 12 | 2 | IPR013032 | |
| Domain | EGF_2 | 1.21e-02 | 265 | 12 | 2 | PS01186 | |
| Pubmed | 1.91e-04 | 60 | 12 | 2 | 19075228 | ||
| Pubmed | 2.38e-04 | 67 | 12 | 2 | 29254152 | ||
| Coexpression | BROCKE_APOPTOSIS_REVERSED_BY_IL6 | 2.70e-05 | 146 | 11 | 3 | M8244 | |
| Coexpression | GSE22033_UNTREATED_VS_ROSIGLITAZONE_TREATED_MEF_DN | 6.80e-05 | 199 | 11 | 3 | M7690 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | 1.09e-05 | 1060 | 12 | 6 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | 5.62e-05 | 1414 | 12 | 6 | facebase_RNAseq_e10.5_Emin_MedNas_2500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 5.71e-05 | 831 | 12 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | 1.31e-04 | 989 | 12 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_F-vs-M_top280_280 | 3.68e-04 | 260 | 12 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_250_F-vs-M | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | 3.95e-04 | 1252 | 12 | 5 | facebase_RNAseq_e10.5_MaxArch_2500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | 4.02e-04 | 1257 | 12 | 5 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.34e-04 | 275 | 12 | 3 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#2_top-relative-expression-ranked_500 | 5.97e-04 | 65 | 12 | 2 | gudmap_developingGonad_P2_ovary_500_k2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | 5.99e-04 | 1370 | 12 | 5 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 6.21e-04 | 311 | 12 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | BM Top 100 - stomach fundus | 7.12e-04 | 71 | 12 | 2 | BM Top 100 - stomach fundus | |
| CoexpressionAtlas | BM Top 100 - stomach cardiac | 7.32e-04 | 72 | 12 | 2 | BM Top 100 - stomach cardiac | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | 8.00e-04 | 1459 | 12 | 5 | facebase_RNAseq_e10.5_Emin_LatNas_2500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000 | 9.63e-04 | 847 | 12 | 4 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#3_top-relative-expression-ranked_500 | 1.32e-03 | 97 | 12 | 2 | gudmap_developingGonad_e18.5_ovary_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#1_top-relative-expression-ranked_500 | 1.43e-03 | 101 | 12 | 2 | gudmap_developingGonad_e14.5_ ovary_500_k1 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#5_top-relative-expression-ranked_500 | 1.67e-03 | 109 | 12 | 2 | gudmap_developingGonad_e16.5_ovary_500_k5 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.59e-05 | 190 | 12 | 3 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.61e-05 | 191 | 12 | 3 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.61e-05 | 191 | 12 | 3 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-05 | 192 | 12 | 3 | 6c106b91e46eabbe686a52a65a9c94ad9cbe9390 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.64e-05 | 192 | 12 | 3 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.79e-05 | 198 | 12 | 3 | 62cbf4b29e8af4983fb47a17f96da62682a5137e | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.79e-05 | 198 | 12 | 3 | af4fb9eb2295c7b90624b38ba25619aa15254efa | |
| ToppCell | LAM-Endothelial-VasEndo-2|Endothelial / Condition, Lineage and Cell class | 1.79e-05 | 198 | 12 | 3 | 92bccaec01f1dbb17d5efcba30f7f800f674ca96 | |
| ToppCell | TCGA-Skin-Metastatic|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.79e-05 | 198 | 12 | 3 | ad39cce004867f083f8da1954e0cf5a263815184 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.82e-05 | 199 | 12 | 3 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Endothelial-Endothelial|Endothelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.85e-05 | 200 | 12 | 3 | 2ae62c428728c1d9d4471d4be24bd6ab074fa22c | |
| ToppCell | Kidney|World / Skin and Kidney Cells in Lupus Nephritis Patients. | 1.85e-05 | 200 | 12 | 3 | 1f99afa1f3c32a2a9cfb4ad33ff4d404e34fac63 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Tmsb4x_(Tmsb4x)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.35e-04 | 86 | 12 | 2 | db67c05c876a5649371c0dc6c941cc371bc2feb8 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Tmsb4x_(Tmsb4x)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.35e-04 | 86 | 12 | 2 | 2778446e035c5585bce28ed0ef93b87b6ad90c6e | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P1-P1_2-Tnr|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.06e-04 | 98 | 12 | 2 | 42875d16ae9fcbaf988cd71be82568f2f862f2dd | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P1-P1_2|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.06e-04 | 98 | 12 | 2 | 7a62a77ca83153dacff4d02d6e32104227d0980d | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P1-P1_2-Tnr-Polydendrocye.Tnr.Pdgfa_(Pdgfa)|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.06e-04 | 98 | 12 | 2 | 26250ea4171a0557a67505839cf79d3fe4d9d41a | |
| ToppCell | ASK440-Endothelial-Endothelium|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.73e-04 | 122 | 12 | 2 | 2f76ec3b527e9528fbb006599a96e8bbdf9e0e62 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_26.46.91|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.28e-04 | 129 | 12 | 2 | 6abdba987c8528f7cb90b32dc01796e02c7352c9 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 6.39e-04 | 142 | 12 | 2 | 0e0f8bb956ff89dc98e8fa56f8acac33e01a26dd | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT1_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.85e-04 | 147 | 12 | 2 | a82a971a934faff6806823ca62a398b429ecd9c8 | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte-pericyte_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 7.22e-04 | 151 | 12 | 2 | 8ba15ab24fe2e71df0a2a7511ca451ad2376bd91 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.61e-04 | 155 | 12 | 2 | e1a20e88b9c0eaf7ca7004acc0eda096d1588563 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 7.71e-04 | 156 | 12 | 2 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.80e-04 | 157 | 12 | 2 | bfec34182f052cf1c0d847ba53ea335d4d1190de | |
| ToppCell | COVID-19_Mild-PLT_0|COVID-19_Mild / Disease Group and Platelet Clusters | 8.61e-04 | 165 | 12 | 2 | 083a14d3b0162cee4e79f7398b8fb739582b39ff | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.72e-04 | 166 | 12 | 2 | 03a47b8687f54955e84df1edcb230db332c4ca8f | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.93e-04 | 168 | 12 | 2 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Rectum_normal_tissue-Rectum_normal_tissue|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 9.03e-04 | 169 | 12 | 2 | 91f4b6a14708e701b2af22989004282041777491 | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Rectum_normal_tissue|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 9.03e-04 | 169 | 12 | 2 | 41cb92b0558f0d5a3e511058efd9110258b88ee3 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.14e-04 | 170 | 12 | 2 | a121e10099faaeb60251eec162f38caf7c4238c2 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.14e-04 | 170 | 12 | 2 | 67d7e1da3ebd2d14cb2e67799e94d655027ed5c4 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.14e-04 | 170 | 12 | 2 | 8e1f757ed62218c0fb6525f49d142dd2cd29acf9 | |
| ToppCell | Endothelial-A-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 9.35e-04 | 172 | 12 | 2 | a3201773a25832e92dd113fad165f1ecd37f5e91 | |
| ToppCell | facs|World / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.35e-04 | 172 | 12 | 2 | a2d0a64ebf09d219a07d6bbad1056bad6d46b9be | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.35e-04 | 172 | 12 | 2 | de9b11ab109d04937186c09772cec9105a935f95 | |
| ToppCell | 3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.46e-04 | 173 | 12 | 2 | b57d14e2c2368304cb903562d06ce8228f53857c | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 9.46e-04 | 173 | 12 | 2 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.57e-04 | 174 | 12 | 2 | 3d4c05ea5719ca65e85d1f15198453034791087c | |
| ToppCell | facs|World / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.68e-04 | 175 | 12 | 2 | 53e96956019f984decc1c81376ebc88fbf3c4d40 | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-basal_epithelial_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.68e-04 | 175 | 12 | 2 | eb87275da6f61ecb4fbc89421dfd27bead1e0f48 | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.68e-04 | 175 | 12 | 2 | 3883675a726dd0c6c3a7113d59be2a093ea2dc6f | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 9.79e-04 | 176 | 12 | 2 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.79e-04 | 176 | 12 | 2 | e74ad0db3b05897edcfabeb11008ede2b9eeb638 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.79e-04 | 176 | 12 | 2 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 9.79e-04 | 176 | 12 | 2 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.79e-04 | 176 | 12 | 2 | 450c25ec5eeb65425f904e0a25aaafdf5682ef9c | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 9.79e-04 | 176 | 12 | 2 | bfa1633e1b7a8a2f04d37fa07284fe9bc0199f46 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.90e-04 | 177 | 12 | 2 | 1921226196b2ab7919d9f843e60d9f4bd9ec9c57 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 9.90e-04 | 177 | 12 | 2 | 3d955ea938a1d2fb1b6d68d4997fd454bd632dfc | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage-stroma-erythroid_macrophage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.90e-04 | 177 | 12 | 2 | b647667da62a91dbe3890820142626e26aa779d2 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.90e-04 | 177 | 12 | 2 | 71919b5c9bfa87fdd2cd44dfa057b66ea081be5d | |
| ToppCell | RV-11._Adipocyte|World / Chamber and Cluster_Paper | 9.90e-04 | 177 | 12 | 2 | f0edf04930692418953e4f00a917257804ec0ffd | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.90e-04 | 177 | 12 | 2 | bd602db857f37869ef76d14c05ef522c509f08ee | |
| ToppCell | RV-11._Adipocyte|RV / Chamber and Cluster_Paper | 1.00e-03 | 178 | 12 | 2 | 278bbea5cf8f0589f71675c7a3d00679391b5253 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-03 | 178 | 12 | 2 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | 367C-Endothelial_cells-Endothelial-B_(Artery)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.00e-03 | 178 | 12 | 2 | e1e96a0e3ff718ebf676a982bc63e8ced6984059 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-B_(Artery)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.00e-03 | 178 | 12 | 2 | 363e8b23b3834692a8a79e5fdc7b43bd3a4dab5e | |
| ToppCell | Endothelial-A-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 1.00e-03 | 178 | 12 | 2 | 2f2602b9305d55f25afa9861dd6c6347ae179337 | |
| ToppCell | Endothelial-A-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 1.01e-03 | 179 | 12 | 2 | 138fd6ba6bdbd0ad01c574168addf720b67a0fea | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.02e-03 | 180 | 12 | 2 | 40d4838a0ccb10d5e49266bc8a0037d27b75ccc2 | |
| ToppCell | RA-11._Adipocyte|RA / Chamber and Cluster_Paper | 1.02e-03 | 180 | 12 | 2 | d48a3d27357f7d184132a6805950f93080146b59 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-4|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 1.02e-03 | 180 | 12 | 2 | 886ebaf9cf8992e8dd13fca799a1d1a2a9ce73d8 | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.03e-03 | 181 | 12 | 2 | ab66a89f316b935d9ba1277426d976b1e9e39757 | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-03 | 182 | 12 | 2 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-03 | 182 | 12 | 2 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-03 | 183 | 12 | 2 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-03 | 183 | 12 | 2 | ec3c05b9ce1e0fbb720e0dea41f1e28fd3fd878f | |
| ToppCell | 390C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.06e-03 | 183 | 12 | 2 | 28e1fc6498aaf8f42c4d6d4fa54ffff4c546d0d1 | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 1.06e-03 | 183 | 12 | 2 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | LA-11._Adipocyte|World / Chamber and Cluster_Paper | 1.06e-03 | 183 | 12 | 2 | b177be283e1553fb1f69a346f1ba79ad00297fa2 | |
| ToppCell | 3'-Adult-SmallIntestine-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-03 | 183 | 12 | 2 | f8212bf8a8b8312434ae030261c558c147f61747 | |
| ToppCell | LA-11._Adipocyte|LA / Chamber and Cluster_Paper | 1.06e-03 | 183 | 12 | 2 | 3f9011976782fa8aa95cdd6f00f07a91094d411b | |
| ToppCell | 390C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.06e-03 | 183 | 12 | 2 | 667d9107af17fd076ceff6b2cbcb78f892fd62d2 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-03 | 183 | 12 | 2 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-03 | 183 | 12 | 2 | 2beb5414958d38a5341870d55229f3b1707e76bf | |
| ToppCell | 3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-03 | 183 | 12 | 2 | 858682df5592c6856487487a7baabd6e60e63a38 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-03 | 184 | 12 | 2 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-03 | 184 | 12 | 2 | 3261d767d5e3d9e9fbac22ad73ca14e44beed89c | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.08e-03 | 185 | 12 | 2 | 9faa35ceb89ccd2979072286f063687c9f846ce3 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-03 | 185 | 12 | 2 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | Endothelial-A-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 1.08e-03 | 185 | 12 | 2 | dee0b7ba2f338f0979d2306aedf52ac35a36b60c | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-03 | 185 | 12 | 2 | afbb88325e4a81c15ac1d0a004e3e1f4ba2ee87b | |
| ToppCell | metastatic_Brain-Endothelial_cells-Stalk-like_ECs|metastatic_Brain / Location, Cell class and cell subclass | 1.08e-03 | 185 | 12 | 2 | ad52970e88e8947ef256095bd4b40229b912d58a | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-03 | 185 | 12 | 2 | 775b72319ef6acffd2c9a74293b9c1bccea33f42 | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|World / Disease state, Lineage and Cell class | 1.08e-03 | 185 | 12 | 2 | 85cb81759589a26d83676cffbf2bc37399683c10 | |
| ToppCell | Endothelial-A-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.08e-03 | 185 | 12 | 2 | ae49c61f6ecf128fe2a958b8c75c83688da75f59 | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 1.08e-03 | 185 | 12 | 2 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.09e-03 | 186 | 12 | 2 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-03 | 186 | 12 | 2 | 7582b5154d8e5a4434817b5ab77a10b789ea2288 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-03 | 187 | 12 | 2 | f20e7a1751694390f535ffb27b97e887220f8695 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL13A1+_matrix_FBs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.10e-03 | 187 | 12 | 2 | e04fb35f2f5b120659d06b5ae427ab1ec56d5c36 | |
| ToppCell | facs-Trachea-nan-24m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-03 | 187 | 12 | 2 | b930d5f7d410ac1f340babec5c937388f64cafc0 | |
| ToppCell | Endothelial-A-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.10e-03 | 187 | 12 | 2 | febe0b99a6a815ce687160a0e7af55228b1d5beb | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-03 | 187 | 12 | 2 | f0c6e53035b00772377c4d5f761b4d11026b911a | |
| ToppCell | Endothelial-A-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.10e-03 | 187 | 12 | 2 | fd93f3f4b82dae3bf4eef245bfedc2a9e3251b61 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.10e-03 | 187 | 12 | 2 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.10e-03 | 187 | 12 | 2 | e35716f8b482be3bf5ab79f087a9caf67a9d197a | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 1.12e-03 | 188 | 12 | 2 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | Endothelial-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.12e-03 | 188 | 12 | 2 | 0824d567356d360fd8e78e840c30529c139f98a1 | |
| Computational | Lung genes. | 1.61e-04 | 434 | 8 | 4 | MODULE_5 | |
| Drug | Luteolin [491-70-3]; Down 200; 14uM; HL60; HT_HG-U133A | 8.98e-05 | 190 | 11 | 3 | 3041_DN | |
| Drug | Isotretinoin [4759-48-2]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 9.13e-05 | 191 | 11 | 3 | 7438_DN | |
| Drug | GSK-3 Inhibitor IX; Down 200; 0.5uM; PC3; HT_HG-U133A | 9.27e-05 | 192 | 11 | 3 | 7106_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 500uM; MCF7; HT_HG-U133A | 9.70e-05 | 195 | 11 | 3 | 6999_UP | |
| Drug | Procyclidine hydrochloride [1508-76-5]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 9.70e-05 | 195 | 11 | 3 | 4817_UP | |
| Drug | Dropropizine (R,S) [17692-31-8]; Up 200; 17uM; PC3; HT_HG-U133A | 1.00e-04 | 197 | 11 | 3 | 5106_UP | |
| Drug | (1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.02e-04 | 198 | 11 | 3 | 4367_DN | |
| Drug | Tolfenamic acid [13710-19-5]; Up 200; 15.2uM; HL60; HG-U133A | 1.02e-04 | 198 | 11 | 3 | 1437_UP | |
| Drug | Cyproheptadine hydrochloride [969-33-5]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 1.03e-04 | 199 | 11 | 3 | 1521_UP | |
| Drug | L-Ft | 6.25e-04 | 78 | 11 | 2 | CID000451514 | |
| Drug | 2-Acetylaminofluorene | 8.53e-04 | 409 | 11 | 3 | ctd:D015073 | |
| Drug | 1-methylcyclopentanecarboxylic acid | 9.25e-04 | 95 | 11 | 2 | CID000138436 | |
| Drug | 15d-PGJ2; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 2.56e-03 | 159 | 11 | 2 | 1011_UP | |
| Drug | Puromycin dihydrochloride [58-58-2]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 2.85e-03 | 168 | 11 | 2 | 5310_UP | |
| Drug | 15d-PGJ2; Up 200; 10uM; MCF7; HT_HG-U133A | 2.88e-03 | 169 | 11 | 2 | 6948_UP | |
| Drug | ICI 182,780; Down 200; 0.01uM; MCF7; HT_HG-U133A | 3.44e-03 | 185 | 11 | 2 | 5235_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 3.44e-03 | 185 | 11 | 2 | 1022_UP | |
| Drug | geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A | 3.44e-03 | 185 | 11 | 2 | 5225_DN | |
| Drug | valinomycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | 3.44e-03 | 185 | 11 | 2 | 5906_UP | |
| Drug | geldanamycin; Up 200; 1uM; PC3; HT_HG-U133A | 3.48e-03 | 186 | 11 | 2 | 1228_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A | 3.51e-03 | 187 | 11 | 2 | 2474_UP | |
| Drug | C768-0445; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 3.59e-03 | 189 | 11 | 2 | 973_UP | |
| Drug | Mianserine hydrochloride [21535-47-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 3.59e-03 | 189 | 11 | 2 | 2231_UP | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 3.59e-03 | 189 | 11 | 2 | 5578_DN | |
| Drug | Gabazine [105538-73-6]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 3.63e-03 | 190 | 11 | 2 | 3253_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A | 3.66e-03 | 191 | 11 | 2 | 2137_UP | |
| Drug | Syrosingopine [84-36-6]; Up 200; 6uM; HL60; HG-U133A | 3.66e-03 | 191 | 11 | 2 | 1761_UP | |
| Drug | Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 3.66e-03 | 191 | 11 | 2 | 6024_DN | |
| Drug | 11-deoxy-16,16-dimethyl Prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A | 3.66e-03 | 191 | 11 | 2 | 7538_UP | |
| Drug | Tiapride hydrochloride [51012-33-0]; Down 200; 11uM; MCF7; HT_HG-U133A | 3.70e-03 | 192 | 11 | 2 | 2292_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; PC3; HT_HG-U133A | 3.70e-03 | 192 | 11 | 2 | 1207_UP | |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 3.70e-03 | 192 | 11 | 2 | 4743_DN | |
| Drug | Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 3.70e-03 | 192 | 11 | 2 | 4746_DN | |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Down 200; 23.6uM; PC3; HT_HG-U133A | 3.70e-03 | 192 | 11 | 2 | 2101_DN | |
| Drug | troglitazone; Down 200; 10uM; HL60; HT_HG-U133A | 3.70e-03 | 192 | 11 | 2 | 1173_DN | |
| Drug | estradiol, USP; Up 200; 0.01uM; MCF7; HT_HG-U133A | 3.70e-03 | 192 | 11 | 2 | 5238_UP | |
| Drug | LY 294002; Down 200; 10uM; HL60; HT_HG-U133A | 3.70e-03 | 192 | 11 | 2 | 2699_DN | |
| Drug | Triflupromazine hydrochloride [1098-60-8]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 3.70e-03 | 192 | 11 | 2 | 7466_DN | |
| Drug | wortmannin from Penicillium funiculosum; Down 200; 0.01uM; HL60; HT_HG-U133A | 3.70e-03 | 192 | 11 | 2 | 2703_DN | |
| Drug | Glycocholic acid [475-31-0]; Down 200; 8.6uM; PC3; HT_HG-U133A | 3.74e-03 | 193 | 11 | 2 | 6716_DN | |
| Drug | Selegiline hydrochloride [14611-52-0]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 3.74e-03 | 193 | 11 | 2 | 4146_DN | |
| Drug | Decamethonium bromide [541-22-0]; Up 200; 9.6uM; HL60; HT_HG-U133A | 3.74e-03 | 193 | 11 | 2 | 2933_UP | |
| Drug | Tetrahydroalstonine [6474-90-4]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 3.74e-03 | 193 | 11 | 2 | 6209_UP | |
| Drug | Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 3.74e-03 | 193 | 11 | 2 | 3258_DN | |
| Drug | Trimethylcolchicinic acid [3482-37-9]; Down 200; 11.6uM; PC3; HT_HG-U133A | 3.74e-03 | 193 | 11 | 2 | 4202_DN | |
| Drug | (+,-)-Synephrine [94-07-5]; Up 200; 24uM; MCF7; HT_HG-U133A | 3.74e-03 | 193 | 11 | 2 | 3578_UP | |
| Drug | Isotretinoin [4759-48-2]; Up 200; 13.4uM; PC3; HT_HG-U133A | 3.74e-03 | 193 | 11 | 2 | 7315_UP | |
| Drug | geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A | 3.74e-03 | 193 | 11 | 2 | 5588_DN | |
| Drug | ICI182,780; Down 200; 1uM; MCF7; HT_HG-U133A | 3.78e-03 | 194 | 11 | 2 | 7534_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | 3.78e-03 | 194 | 11 | 2 | 7001_UP | |
| Drug | 5248896; Up 200; 11uM; MCF7; HT_HG-U133A_EA | 3.78e-03 | 194 | 11 | 2 | 955_UP | |
| Drug | Harmol hydrochloride monohydrate [40580-83-4]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 3.78e-03 | 194 | 11 | 2 | 2900_DN | |
| Drug | Dosulepin hydrochloride [897-15-4]; Down 200; 12uM; MCF7; HT_HG-U133A | 3.78e-03 | 194 | 11 | 2 | 2864_DN | |
| Drug | Bepridil hydrochloride [74764-40-2]; Down 200; 10uM; MCF7; HT_HG-U133A | 3.78e-03 | 194 | 11 | 2 | 5674_DN | |
| Drug | BAS 012416453; Down 200; 38uM; PC3; HT_HG-U133A | 3.78e-03 | 194 | 11 | 2 | 6876_DN | |
| Drug | Scopolamine hydrochloride [55-16-3]; Down 200; 11.8uM; PC3; HT_HG-U133A | 3.78e-03 | 194 | 11 | 2 | 4219_DN | |
| Drug | Mebeverine hydrochloride [2753-45-9]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 3.78e-03 | 194 | 11 | 2 | 3193_DN | |
| Drug | Nocodazole [31430-18-9]; Up 200; 13.2uM; PC3; HT_HG-U133A | 3.78e-03 | 194 | 11 | 2 | 2076_UP | |
| Drug | Terfenadine [50679-08-8]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 3.78e-03 | 194 | 11 | 2 | 6823_DN | |
| Drug | Demeclocycline hydrochloride [64-73-3]; Down 200; 8uM; MCF7; HT_HG-U133A | 3.78e-03 | 194 | 11 | 2 | 3604_DN | |
| Drug | SB 203580; Down 200; 1uM; MCF7; HT_HG-U133A | 3.78e-03 | 194 | 11 | 2 | 6915_DN | |
| Drug | Dienestrol [84-17-3]; Up 200; 15uM; MCF7; HT_HG-U133A | 3.78e-03 | 194 | 11 | 2 | 6208_UP | |
| Drug | Tiletamine hydrochloride; Down 200; 15.4uM; MCF7; HT_HG-U133A | 3.78e-03 | 194 | 11 | 2 | 6516_DN | |
| Drug | estradiol, USP; Down 200; 0.01uM; HL60; HT_HG-U133A | 3.81e-03 | 195 | 11 | 2 | 2701_DN | |
| Drug | Propofol [2078-54-8]; Down 200; 22.4uM; HL60; HT_HG-U133A | 3.81e-03 | 195 | 11 | 2 | 3048_DN | |
| Drug | Sulindac [38194-50-2]; Up 200; 11.2uM; PC3; HT_HG-U133A | 3.81e-03 | 195 | 11 | 2 | 1815_UP | |
| Drug | Triflusal [322-79-2]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 3.81e-03 | 195 | 11 | 2 | 2867_DN | |
| Drug | PHA-00767505E [723337-45-9]; Up 200; 10uM; PC3; HT_HG-U133A | 3.81e-03 | 195 | 11 | 2 | 6545_UP | |
| Drug | Reserpinic acid hydrochloride; Up 200; 9.2uM; MCF7; HT_HG-U133A | 3.81e-03 | 195 | 11 | 2 | 7323_UP | |
| Drug | Talampicillin hydrochloride [39878-70-1]; Up 200; 7.8uM; PC3; HT_HG-U133A | 3.81e-03 | 195 | 11 | 2 | 7254_UP | |
| Drug | Atovaquone [95233-18-4]; Down 200; 11uM; PC3; HT_HG-U133A | 3.81e-03 | 195 | 11 | 2 | 4201_DN | |
| Drug | Palmatine chloride [3486-67-7]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 3.81e-03 | 195 | 11 | 2 | 2795_UP | |
| Drug | 15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A | 3.81e-03 | 195 | 11 | 2 | 5228_DN | |
| Drug | prochlorperazine dimaleate salt; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 3.81e-03 | 195 | 11 | 2 | 1053_DN | |
| Drug | Deoxycorticosterone [64-85-7]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 3.81e-03 | 195 | 11 | 2 | 5357_DN | |
| Drug | (-) -Levobunolol hydrochloride [27912-14-7]; Up 200; 12.2uM; PC3; HT_HG-U133A | 3.81e-03 | 195 | 11 | 2 | 4016_UP | |
| Drug | Letrozole [112809-51-5]; Down 200; 14uM; HL60; HT_HG-U133A | 3.81e-03 | 195 | 11 | 2 | 2916_DN | |
| Drug | radicicol; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 3.81e-03 | 195 | 11 | 2 | 953_DN | |
| Drug | Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; PC3; HT_HG-U133A | 3.81e-03 | 195 | 11 | 2 | 3984_DN | |
| Drug | Chlortetracycline hydrochloride [64-72-2]; Up 200; 7.8uM; PC3; HT_HG-U133A | 3.81e-03 | 195 | 11 | 2 | 6761_UP | |
| Drug | Prazosin hydrochloride [19237-84-4]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 3.81e-03 | 195 | 11 | 2 | 5416_DN | |
| Drug | Azathymine, 6 [932-53-6]; Down 200; 31.4uM; MCF7; HT_HG-U133A | 3.81e-03 | 195 | 11 | 2 | 4106_DN | |
| Drug | Acemetacin [53164-05-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 3.81e-03 | 195 | 11 | 2 | 5460_DN | |
| Drug | Molindone hydrochloride [15622-65-8]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 3.81e-03 | 195 | 11 | 2 | 4784_DN | |
| Drug | Risperidone [106266-06-2]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 3.81e-03 | 195 | 11 | 2 | 3508_DN | |
| Drug | Butylparaben [94-26-8]; Down 200; 20.6uM; HL60; HT_HG-U133A | 3.85e-03 | 196 | 11 | 2 | 3069_DN | |
| Drug | PHA-00767505E [723337-45-9]; Down 200; 10uM; MCF7; HT_HG-U133A | 3.85e-03 | 196 | 11 | 2 | 6596_DN | |
| Drug | Fluoxetine hydrochloride [59333-67-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 3.85e-03 | 196 | 11 | 2 | 3314_UP | |
| Drug | Hesperidin [520-26-3]; Down 200; 6.6uM; HL60; HT_HG-U133A | 3.85e-03 | 196 | 11 | 2 | 1294_DN | |
| Drug | Nifenazone [2139-47-1]; Up 200; 13uM; PC3; HT_HG-U133A | 3.85e-03 | 196 | 11 | 2 | 7314_UP | |
| Drug | Sulfadimethoxine [122-11-2]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 3.85e-03 | 196 | 11 | 2 | 4724_UP | |
| Drug | Flumethasone [2135-17-3]; Down 200; 9.8uM; HL60; HT_HG-U133A | 3.85e-03 | 196 | 11 | 2 | 2551_DN | |
| Disease | Multiple Myeloma | 1.29e-04 | 42 | 12 | 2 | C0026764 | |
| Disease | Colorectal Carcinoma | 1.35e-04 | 702 | 12 | 4 | C0009402 | |
| Disease | response to anticonvulsant | 5.31e-04 | 85 | 12 | 2 | GO_0036277 | |
| Disease | renal cell carcinoma (is_marker_for) | 1.20e-03 | 128 | 12 | 2 | DOID:4450 (is_marker_for) | |
| Disease | prostate cancer (is_marker_for) | 1.77e-03 | 156 | 12 | 2 | DOID:10283 (is_marker_for) | |
| Disease | myocardial infarction (biomarker_via_orthology) | 1.86e-03 | 160 | 12 | 2 | DOID:5844 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SSNSHSHSEKSSVFY | 951 | Q8TCU4 | |
| DHRLHSDHRSSSEYT | 1636 | O14646 | |
| SDHRSSSEYTHHKSS | 1641 | O14646 | |
| LSSHHKKSSEEHEYS | 51 | Q86V24 | |
| SFSSDRSHTLSHASY | 901 | Q01484 | |
| HHKDHSDSESTSSDN | 1056 | O15550 | |
| ASHSTKTDASSTHHS | 1006 | P15941 | |
| RTSSDHTDHTYLSST | 546 | Q9ULI3 | |
| SHSYSSSHSNASHAR | 196 | Q7RTS6 | |
| TASHKEHSRLSHTSS | 936 | Q9P2Q2 | |
| SYVKHTSTEHTSSSR | 206 | P10643 | |
| HHSDTVHYGQSSSSK | 651 | Q68DL7 | |
| AFHSSSSYHRHERSH | 286 | Q9H0M5 |